Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients

The Impact of Preoperative Serum Anti-TNFα Therapy Levels on Early Postoperative Outcomes in Inflammatory Bowel Disease Surgery

(2015) Cheryl Lau et al.   ANNALS OF SURGERY

Preoperative infliximab use and postoperative complications in Crohn's disease: A systematic review and meta-analysis

(2014) Zhi-Ping Yang et al.   International Journal of Surgery

Meta-analysis: peri-operative anti-TNFα treatment and post-operative complications in patients with inflammatory bowel disease

(2013) N. Narula et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Anti-Tumor Necrosis Factor Therapy Is Associated With Infections after Abdominal Surgery in Crohn's Disease Patients

(2013) Ali Syed et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Risk Factors for Surgical Site Infection and Association With Infliximab Administration During Surgery for Crohn’s Disease

(2013) Motoi Uchino et al.   DISEASES OF THE COLON & RECTUM

Operative Strategy Modifies Risk of Pouch-related Outcomes in Patients With Ulcerative Colitis on Preoperative Anti-Tumor Necrosis Factor-α Therapy

(2013) Jinyu Gu et al.   DISEASES OF THE COLON & RECTUM

The risks of post-operative complications following pre-operative infliximab therapy for Crohn's disease in patients undergoing abdominal surgery: A systematic review and meta-analysis

(2013) Greg Rosenfeld et al.   Journal of Crohns & Colitis

Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis

(2013) Vincent Billioud et al.   Journal of Crohns & Colitis

Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease

(2012) Matti Waterman et al.   GUT

Anti-tumor necrosis factor and postoperative complications in Crohnʼs disease: systematic review and meta-analysis

(2012) Uri Kopylov et al.   INFLAMMATORY BOWEL DISEASES

Infliximab Does Not Affect Postoperative Complication Rates in Crohnʼs Patients Undergoing Abdominal Surgery

(2011) Michael S. Kasparek et al.   INFLAMMATORY BOWEL DISEASES

Ulcerative Colitis

(2011) Silvio Danese et al.   NEW ENGLAND JOURNAL OF MEDICINE

Trends in Surgery for Crohnʼs Disease in the Era of Infliximab

(2010) Douglas W. Jones et al.   ANNALS OF SURGERY

Surgical resection in Crohn’s disease: is immunosuppressive medication associated with higher postoperative infection rates?

(2010) J. Canedo et al.   Colorectal Disease

Perioperative Anti-Tumor Necrosis Factor Therapy Does Not Increase the Rate of Early Postoperative Complications in Crohn’s Disease

(2010) Basil S. Nasir et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Meta-analysis: pre-operative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis

(2009) Z. YANG et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Small bowel resection rates in Crohnʼs disease and the indication for surgery over time: Experience from a large tertiary care center

(2009) Mark Lazarev et al.   INFLAMMATORY BOWEL DISEASES

Perioperative Treatment with Infliximab in Patients with Crohn’s Disease and Ulcerative Colitis is Not Associated with an Increased Rate of Postoperative Complications

(2008) Hiroko Kunitake et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Use of Infliximab within 3 Months of Ileocolonic Resection is Associated with Adverse Postoperative Outcomes in Crohn’s Patients

(2008) Kweku A. Appau et al.   JOURNAL OF GASTROINTESTINAL SURGERY